Novel SERCA2 inhibitor Diphyllin displays anti-tumor effect in non-small cell lung cancer by promoting endoplasmic reticulum stress and mitochondrial dysfunction
2024 · Cancer Letters · 16 citations
https://doi.org/10.1016/j.canlet.2024.217075
Z
Zhiyong Xu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
20
Papers
415
Citations
7
h-index
6
i10-index
Zhiyong Xu is an academic researcher from Tongji University. The author has contributed to research in topics: Advanced Radiotherapy Techniques & Lung Cancer Diagnosis and Treatment & Radiation Therapy and Dosimetry. The author has an h-index of 7, co-authored 17 publications.
ORCID: 0009-0004-3308-4498Papers by this author
worksAcute and chronic toxicity in Sprague–Dawley rats of orally-administered total lignans from Arctii Fructus, a potential therapeutic drug for diabetes
2023 · Regulatory Toxicology and Pharmacology · 3 citations
https://doi.org/10.1016/j.yrtph.2023.105542
Oral acute and subacute toxicity studies as well as safety pharmacology in beagle dogs of total lignans from <i>Arctii Fructus</i>
2025 · Drug and Chemical Toxicology · 0 citations
https://doi.org/10.1080/01480545.2025.2519186
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat